Sale!

PPP2R2B Gene Spinocerebellar Ataxia Type 12 Autosomal Dominant Genetic Test

Original price was: KSh 56,000.Current price is: KSh 40,000.

-29%

The PPP2R2B Gene Spinocerebellar Ataxia Type 12 Autosomal Dominant NGS Genetic DNA Test is a vital diagnostic tool for identifying genetic mutations associated with neurological disorders. Priced at KSh 56,000, this test helps in understanding the genetic basis of Spinocerebellar Ataxia, allowing for early intervention and management. With a turnaround time of 3 to 4 weeks, patients can expect comprehensive insights into their genetic health. Book your test today!

ISO‑Level Quality for Every Test

  • Call Us on 0119023975 to talk with DNA test expert
  • Accurate, Clinician‑Ready Test Reports
  • Advanced DNA & Genetic Testing Assurance
  • Trusted Genetic & DNA Test Results

Chat on WhatsApp

Guaranteed Safe Checkout

PPP2R2B Gene Spinocerebellar Ataxia Type 12 Autosomal Dominant NGS Genetic DNA Test

Introduction to the Test

The PPP2R2B Gene Spinocerebellar Ataxia Type 12 Autosomal Dominant NGS Genetic DNA Test is a groundbreaking diagnostic tool that plays a crucial role in the identification of genetic mutations linked to neurological disorders. Spinocerebellar ataxia type 12 (SCA12) is a hereditary condition characterized by progressive loss of coordination and balance, leading to significant impairment in daily activities. Understanding your genetic predisposition to SCA12 can empower proactive health management.

What the Test Measures

This test specifically measures mutations in the PPP2R2B gene, which are known to contribute to the development of Spinocerebellar Ataxia Type 12. By utilizing Next Generation Sequencing (NGS) technology, the test provides precise and reliable results that are crucial for effective diagnosis.

Who Should Consider This Test?

Individuals with a family history of neurological disorders, particularly those exhibiting symptoms such as unsteady gait, difficulty with fine motor tasks, and balance issues, should consider this test. Risk factors include a family pedigree indicating hereditary ataxia, especially if multiple family members are affected.

Benefits of Taking the Test

  • Early identification of genetic predispositions to SCA12.
  • Informed decision-making regarding treatment and management options.
  • Support for family planning and counseling based on genetic findings.
  • Access to specialized care from neurologists and geneticists.

Understanding Your Results

Results from the PPP2R2B Gene Spinocerebellar Ataxia Type 12 test will be communicated clearly, providing insights into the presence or absence of genetic mutations. It is crucial to discuss these results with a healthcare provider or genetic counselor to understand their implications fully.

Test Pricing

Test Name Discount Price Regular Price
PPP2R2B Gene Spinocerebellar Ataxia Type 12 Autosomal Dominant NGS Genetic DNA Test 40,000 KSh 56,000 KSh

Book Your Test Today!

DNA Labs Kenya has branches across major cities including Nairobi, Mombasa, and Kisumu. We also offer home sample collection services for your convenience. Contact us at +254119023975to book your test now!

Turnaround time for results is approximately 3 to 4 weeks, and the sample type required is either blood or extracted DNA, including a drop of blood on an FTA card. Prior to testing, a genetic counseling session is recommended to draw a pedigree chart of family members affected by SCA12.